{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:58:03Z","timestamp":1792119483608,"version":"4.4.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/14740338.2021.1921734","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T21:15:22Z","timestamp":1619126122000},"page":"877-882","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Expert opinion on sonidegib efficacy, safety and tolerability"],"prefix":"10.1080","volume":"20","author":[{"given":"Alessia","family":"Villani","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Costa","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Sofia","family":"Ocampo-Garza","sequence":"additional","affiliation":[{"name":"Dermatology Department, University Hospital \u00a8Dr. Jos\u00e9 Eleuterio Gonz\u00e1lez\u00a8, Universidad Aut\u00f3noma De Nuevo Le\u00f3n, Monterrey, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-0964","authenticated-orcid":false,"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[{"name":"First Department of Dermatology, Aristotle University, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Scalvenzi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.060"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.19"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2014.08.036"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2031"},{"key":"cit0005","first-page":"94","volume":"17","author":"Lang BM","year":"2019","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S1011-1344(01)00198-1"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00382-y"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.06.003"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00378-8"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.270"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08666.x"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1837773"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1177\/1758834016653605"},{"key":"cit0014","unstructured":"Genentech (2015) Erivedge_ (vismodegib) capsules, for oral use: US pre-scribing infomation. https:\/\/www.erivedge.com\/. Accessed 2016 Jan 13"},{"key":"cit0015","unstructured":"European Medicines Agency (2015) Erivedge 150 mg hard capsules: summary of product characteristics. https:\/\/www.ema.europa.eu\/. Accessed 2016 Jan 13"},{"key":"cit0016","unstructured":"Novartis (2015) Odomzo_ (sonidegib) capsules, for oral use: US prescribing infomation. www.odomzo.com\/. Accessed 2015 Jan 13"},{"key":"cit0017","unstructured":"European Medicines Agency (2015) Odomzo_ 200 mg hard capsules: summary of product characteristics. https:\/\/www.ema.europa.eu\/. Accessed 2016 Jan 13"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00323-4"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1038\/287795a0"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2503"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2006.12.011"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0458-y"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2468-y"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1710"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70100-2"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1021\/ml1000307"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-2982-1"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2020.11.003"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0118"},{"key":"cit0030","volume-title":"24th EADV congress","author":"Lear J","year":"2015"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14542"},{"key":"cit0032","author":"Dummer R","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"cit0033","first-page":"SS0190","volume":"84","author":"Dummer R","journal-title":"J Am Acad Dermatol"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19501"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16230"},{"issue":"6","key":"cit0036","first-page":"e14200","volume":"33","author":"Villani A","journal-title":"Dermatol Ther"},{"key":"cit0037","author":"Villani A","journal-title":"J Am Acad Dermatol"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14511"},{"issue":"6","key":"cit0039","first-page":"758","volume":"84","author":"Scalvenzi M","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2021.1921734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T07:46:10Z","timestamp":1630655170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2021.1921734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/14740338.2021.1921734"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2021.1921734","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}